Clinical Fellow - Hepato-Pancreato-Biliary & Oesophago-Gastric

The post holder will be involved in all aspects of the management of patients with HBP and OG. These include (but are not limited to) the screening of referrals, active participation in MDT, assessment of patients, consent, review of patients on pre-treatment, treatment, planning of SABR, review and approval of SABR plans, precision radiotherapy development and post treatment and ePROMS. All of this will be done under the clinical supervision of the designated HPB & OG team consultant. You will be expected to teach junior medical staff, medical students and nurses on occasion. You will be expected to take part in audit and research. There is no on call responsibility with this post., This post is for 40 hours per week as a Clinical Fellow is work within the clinical oncology Hepato-Pancreato-Biliary (HPB) and) Oesophago-Gastric (OG) disease group, with a strong interest in SABR (Stereotactic Ablative Radiotherapy) for a fixed term period of 12 months. The post holder will be employed by The Christie NHS Foundation Trust and will be predominantly based at The Christie at Withington site, with potential rotation to the radiotherapy satellite centres. Role Purpose

• The appointee will be a Fellow in the department of Clinical Oncology within the HPB & OG disease group
• The employing authority is The Christie NHS Foundation Trust
• The appointee will be managerially accountable to the Clinical Director of the Directorate of Clinical Oncology
• The Appointee will be professionally responsible to the consultants in whose clinics they will be supporting.
• The post-holder will be assigned a clinical supervisor (Consultant Clinical Oncologist). They will work alongside their supervisor in at least one clinic.
• Will develop expertise in the development, management and treatment of HPB and oligometastatic tumour sites with SABR The successful applicant would be expected to work alongside consultants and trainees in out-patient clinics, supervising Technical Radiotherapy delivery and performing on-treatment reviews and follow-up assessments., The medical establishment provides currently consists of 59 Consultants who run the clinical service and research practice. There is also a team of 23 SpRs plus Academic Clinical Fellows. The appointee will be based at The Christie and will provide senior input to all aspects of the management of patients with HBP, OG and oligometastatic disease. These include (but are not limited to) the screening of referrals, active participation in MDT, assessment of patients, consent, review of patients on pre-treatment, treatment, planning of SABR, review and approval of SABR plans, technical radiotherapy development and post treatment and ePROMS. All of this will be done under the clinical supervision of the designated HPB/OG team consultant. They will be expected to teach junior medical staff, medical students and nurses on occasion. They will be expected to take part in audit and research. There is no on call responsibility with this post. [JD Template: December 2023] 1 Continuing Professional Development The Trust supports the requirements for continuing professional development (CPD) as laid down by the GMC and surgical colleges and is committed to providing time and financial support for these activities. Role Planning The timetable below is indicative and will be confirmed on commencement in post. Monday Tuesday Wednesday Thursday Friday AM Clinic TBS review clinic Admin / Liver SABR MDT Clinic/ Pelvic MDT Renal SABR MDT ( alt weeks) Radiotherapy planning PM Admin / Bone SABR MDT Clinic Radiotherapy planning Admin Training NB This timetable is indicative On call Commitments This role does not require participation in the on-call rota. The closing date for this post may be extended if there are insufficient applicants or brought forward if there is a high volume of applicants. We want to ensure that everyone who works at the Christie or uses our services is welcomed, valued and treated with dignity and respect. The Christie values diversity and is committed to ensuring equal opportunities for all and fair representation across the organisation at all levels. In support of these commitments, we particularly welcome applications from Black, Asian and other ethnic minority people and people with disabilities for this post. Appointment will be only on merit. We are committed to creating a balanced and diverse workforce. As such we welcome and encourage applications from people of all backgrounds. Together we will foster inclusion and tackle inequity and health inequalities in cancer care. As users of the disability confident scheme, we guarantee to interview all disabled applicants who meet the minimum criteria for the vacancy All positions within the Christie are subject to the receipt of satisfactory written references, medical clearance and evidence of your Right to Work in the UK. Some roles will require a Disclosure & Barring Service (DBS) check. Please note if you are successfully appointed to a post with this Trust, you will be required to pay for your own DBS Disclosure. By applying for this post you are agreeing to The Christie NHS Foundation Trust transferring the information contained in this application to its preferred applicant management system. If you are offered a job information will also be transferred into the national NHS Electronic Staff Records system. Please note, all communication regarding your application will be made via email, please ensure you check your junk/spam folders as emails are sometimes filtered there. If you have not heard from us within four weeks of the closing date, I regret that on this occasion your application will have been unsuccessful. The Inter-Authority Transfer (IAT) process is a critical and beneficial component of ESR and will form part of the recruitment process. In the event that you are successful following interview your previous NHS employment data, if applicable will be transferred from your current / most recent employer. Overseas candidates wishing to apply for this position and who would require immigration sponsorship, may wish to self-assess the likelihood of obtaining a Certificate of Sponsorship for the post on the UKVI website. You should be aware the Trust operates a No Smoking Policy and therefore employees are not permitted to smoke at work.
  
  The Christie is one of Europe's leading cancer centres, treating over 60,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester & Cheshire, but as a national specialist around 15% patients are referred to us from other parts of the country. We provide radiotherapy through one of the largest radiotherapy departments in the world; chemotherapy on site and through 14 other hospitals; highly specialist surgery for complex and rare cancer; and a wide range of support and diagnostic services. We are also an international leader in research, with world first breakthroughs for over 100 years. We run one of the largest early clinical trial units in Europe with over 300 trials every year. Cancer research in Manchester, most of which is undertaken on the Christie site, has been officially ranked the best in the UK.
  
  The Christie NHS Foundation Trust serves a population of 3 million people within the Greater Manchester and Cheshire Cancer Network, providing surgery, radiotherapy and complex chemotherapy services. Applications are welcomed for a 12 month HPB & OG Clinical Fellow, post commencing January 2025 in Clinical Oncology, based at The Christie NHS FT, Manchester, UK Europe's largest single site cancer hospital. This post is for 40 hours per week as a Clinical Fellow within the HPB and OG disease group under the specialty of Clinical Oncology for a fixed term period of 12 months. The post holder will be employed by The Christie NHS Foundation Trust and will be based at The Christie. The successful applicant would be expected to work alongside consultants and trainees in out-patient clinics, supervising Precision Radiotherapy planning/delivery and performing on-treatment reviews and follow-up assessments.